sparfloxacin has been researched along with Torsade de Pointes in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (10.00) | 18.2507 |
2000's | 6 (60.00) | 29.6817 |
2010's | 3 (30.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brown, AM; Bruening-Wright, A; Kramer, J; Kuryshev, YA; Myatt, G; Obejero-Paz, CA; Verducci, JS | 1 |
Kang, W; Kim, EJ; Lee, HW; Lim, MS; Noh, K; Park, J; Seo, JJ; Seong, SJ; Yoon, YR | 1 |
Bae, YM; Cho, H; Kim, B; Kim, HJ; Kim, JG; Kim, KS; Leem, CH; Park, SW; Shin, HC; Sung, DJ; Won, KJ; Zhang, YH | 1 |
Byotra, SP; Kakar, A | 1 |
Sugiyama, A | 1 |
Ahluwalia, G | 1 |
Chiba, K; Hashimoto, K; Sugiyama, A; Takasuna, K | 1 |
Gallacher, DJ; Lu, HR; Van de Water, A; Vlaminckx, E | 1 |
Dupont, H; Gachot, B; Regnier, B; Souweine, B; Timsit, JF; Wolff, M | 1 |
Chiba, K; Hashimoto, K; Satoh, Y; Shiina, H; Sugiyama, A | 1 |
1 review(s) available for sparfloxacin and Torsade de Pointes
Article | Year |
---|---|
[Effects of clinically available drugs on the repolarization process of the heart assessed by the in vivo canine models].
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Antipsychotic Agents; Antitubercular Agents; Cation Transport Proteins; Cisapride; Disease Models, Animal; Dogs; Ether-A-Go-Go Potassium Channels; Fluoroquinolones; Gastrointestinal Agents; Haloperidol; Histamine H1 Antagonists; Long QT Syndrome; Potassium Channels; Potassium Channels, Voltage-Gated; Sulpiride; Terfenadine; Torsades de Pointes | 2003 |
9 other study(ies) available for sparfloxacin and Torsade de Pointes
Article | Year |
---|---|
MICE models: superior to the HERG model in predicting Torsade de Pointes.
Topics: ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Theoretical; Patch-Clamp Techniques; Predictive Value of Tests; Torsades de Pointes | 2013 |
Pharmacometabolomic approach to predict QT prolongation in guinea pigs.
Topics: Animals; Electrocardiography; Fluoroquinolones; Guinea Pigs; Male; Metabolic Networks and Pathways; Metabolome; Metabolomics; Phenotype; Prognosis; Sotalol; Torsades de Pointes | 2013 |
Impaired Inactivation of L-Type Ca2+ Current as a Potential Mechanism for Variable Arrhythmogenic Liability of HERG K+ Channel Blocking Drugs.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Calcium Channels, L-Type; Calcium Signaling; Cells, Cultured; Drug Evaluation, Preclinical; Ether-A-Go-Go Potassium Channels; Fluoroquinolones; Heart Ventricles; Mice; Myocardial Contraction; Myocytes, Cardiac; Potassium Channel Blockers; Rats, Sprague-Dawley; Torsades de Pointes | 2016 |
Torsade de pointes probably induced by sparfloxacin.
Topics: Adult; Anti-Infective Agents; Antitubercular Agents; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Torsades de Pointes; Tuberculosis, Pulmonary | 2002 |
Torsade de pointes probably induced by sparfloxain.
Topics: Adult; Diagnosis, Differential; Female; Fluoroquinolones; Humans; India; Long QT Syndrome; Torsades de Pointes; Tuberculosis, Pulmonary | 2003 |
Comparison of sensitivity of surrogate markers of drug-induced torsades de pointes in canine hearts.
Topics: Action Potentials; Animals; Biomarkers; Dogs; Electrocardiography; Female; Fluoroquinolones; Heart; Heart Rate; Torsades de Pointes | 2004 |
Calmodulin antagonist W-7 prevents sparfloxacin-induced early afterdepolarizations (EADs) in isolated rabbit purkinje fibers: importance of beat-to-beat instability of the repolarization.
Topics: Animals; Calcium-Calmodulin-Dependent Protein Kinases; Electrophysiologic Techniques, Cardiac; Enzyme Inhibitors; Female; Fluoroquinolones; Heart Rate; In Vitro Techniques; Purkinje Fibers; Rabbits; Sulfonamides; Torsades de Pointes | 2006 |
Torsades de pointe probably related to sparfloxacin.
Topics: Anti-Infective Agents; Female; Fluoroquinolones; Humans; Mastoiditis; Middle Aged; Otitis Media; Pneumococcal Infections; Quinolones; Torsades de Pointes | 1996 |
Proarrhythmic effects of fluoroquinolone antibacterial agents: in vivo effects as physiologic substrate for torsades.
Topics: Action Potentials; Animals; Anti-Infective Agents; Dogs; Electrocardiography, Ambulatory; Female; Fluoroquinolones; Heart; Heart Block; Levofloxacin; Long QT Syndrome; Male; Models, Animal; Ofloxacin; Torsades de Pointes; Ventricular Dysfunction, Right | 2000 |